Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erin A Dean

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Frontiers in Immunology|February 6, 2026
T-cell exhaustion due to BiTE therapy in multiple myeloma: mitigating infectious risks through treatment-free intervalsErin A Dean
Frontiers in Immunology|April 6, 2026
CAR T-cell therapy induced pseudoprogressionErin A Dean
Journal of the Academy of Consultation-Liaison Psychiatry|July 2, 2021
Psychiatric Sequelae of Anti-Dipeptidyl Peptidase-Like Protein-6 Encephalitis: A Case Report and Review of the LiteratureErin A Dean, Christopher L Sola
Case Reports in Oncology|January 10, 2024
Exacerbations of Persistent Neurotoxicity following Axicabtagene Ciloleucel in a Patient with Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Case ReportGraeme A Fenton, Erin A Dean
Case Reports in Oncology|September 26, 2022
Viral Clearance with Neutrophil Recovery in a Patient with Active COVID-19 Infection and Refractory Acute Myeloid Leukemia Who Underwent Successful Reinduction with Cytarabine/IdarubicinErin A Dean, Randy A Brown, Pavneet Kaur, et al.
Cleveland Clinic Journal of Medicine|December 3, 2021
Neuropsychiatric assessment and management of the ICU survivorErin A Dean, Michelle Biehl, Kathryn Bash, et al.
Radiology Case Reports|January 20, 2023
Pattern of brexucabtagene autoleucel-related neurotoxicity on magnetic resonance imaging of the brain in a patient with relapsed/refractory B-cell acute lymphoblastic leukemia and prior leptomeningeal diseaseErin A Dean, Keith R Peters, Carolyn B Adams, et al.
Frontiers in Oncology|August 22, 2025
Case Report: Reactive T-cell large granular lymphocytes in the bone marrow of a patient with relapsed/refractory multiple myeloma receiving teclistamabErin A Dean, Li-Jun Yang, Robert P Seifert, et al.
Blood Neoplasia|July 30, 2025
Gut <i>Faecalibacterium</i> abundance in patients with plasma cell disorders is associated with survival after autologous HSCTErin A Dean, Arkaprava Roy, Rick Y Lin, et al.
Frontiers in Immunology|March 6, 2023
Repeatability of metabolic tumor burden and lesion glycolysis between clinical readersJung W Choi, Erin A Dean, Hong Lu, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Frontiers in Immunology|February 6, 2026
T-cell exhaustion due to BiTE therapy in multiple myeloma: mitigating infectious risks through treatment-free intervalsErin A Dean
Frontiers in Immunology|April 6, 2026
CAR T-cell therapy induced pseudoprogressionErin A Dean
Journal of the Academy of Consultation-Liaison Psychiatry|July 2, 2021
Psychiatric Sequelae of Anti-Dipeptidyl Peptidase-Like Protein-6 Encephalitis: A Case Report and Review of the LiteratureErin A Dean, Christopher L Sola
Case Reports in Oncology|January 10, 2024
Exacerbations of Persistent Neurotoxicity following Axicabtagene Ciloleucel in a Patient with Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Case ReportGraeme A Fenton, Erin A Dean
Case Reports in Oncology|September 26, 2022
Viral Clearance with Neutrophil Recovery in a Patient with Active COVID-19 Infection and Refractory Acute Myeloid Leukemia Who Underwent Successful Reinduction with Cytarabine/IdarubicinErin A Dean, Randy A Brown, Pavneet Kaur, et al.
Cleveland Clinic Journal of Medicine|December 3, 2021
Neuropsychiatric assessment and management of the ICU survivorErin A Dean, Michelle Biehl, Kathryn Bash, et al.
Radiology Case Reports|January 20, 2023
Pattern of brexucabtagene autoleucel-related neurotoxicity on magnetic resonance imaging of the brain in a patient with relapsed/refractory B-cell acute lymphoblastic leukemia and prior leptomeningeal diseaseErin A Dean, Keith R Peters, Carolyn B Adams, et al.
Frontiers in Oncology|August 22, 2025
Case Report: Reactive T-cell large granular lymphocytes in the bone marrow of a patient with relapsed/refractory multiple myeloma receiving teclistamabErin A Dean, Li-Jun Yang, Robert P Seifert, et al.
Blood Neoplasia|July 30, 2025
Gut <i>Faecalibacterium</i> abundance in patients with plasma cell disorders is associated with survival after autologous HSCTErin A Dean, Arkaprava Roy, Rick Y Lin, et al.
Frontiers in Immunology|March 6, 2023
Repeatability of metabolic tumor burden and lesion glycolysis between clinical readersJung W Choi, Erin A Dean, Hong Lu, et al.
Pageof 3